LEP and cancer: Anti-inflammatory adiponectin inhibits cellular metabolism, suppresses growth and tumor formation, inhibits the cell regulatory cycle, stimulates apoptosis [6], may affect cancer retardation through its insulin-sensitizing effects, and through interactions with other hormones (such as leptin, estrogen and insulin) may achieve an antitumor effect [6,7].